非典型 B 细胞在乳腺癌中的预后价值。
Prognostic value of atypical B cells in breast cancer.
发表日期：2024 Sep 30
作者：
Esmeralda García-Torralba, Lorenzo Galluzzi, Aitziber Buqué
来源：
Trends in Cancer
摘要：
肿瘤浸润 B 细胞对乳腺癌 (BRCA) 结局的影响仍知之甚少。杨等人的最新发现。鉴定出一种非典型、克隆性扩增的活化 Fc 受体样 4 (FCRL4) B 细胞群，该细胞群与改善受各种肿瘤类型（包括 BRCA）影响的患者的总体生存率相关。版权所有 © 2024 Elsevier Inc. 保留所有权利。
The impact of tumor-infiltrating B cells on breast cancer (BRCA) outcomes remains poorly understood. Recent findings from Yang et al. identify an atypical, clonally expanded population of activated Fc receptor-like 4 (FCRL4)+ B cells that is associated with improved overall survival in patients affected by various tumor types, including BRCA.Copyright © 2024 Elsevier Inc. All rights reserved.